Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer Stage IV

Explore clinical trials studying Breast Cancer Stage IV. Study availability and eligibility vary by location and protocol.

37 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer Stage IV trial results

Recruiting

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

NCT07459673

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +6 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

NCT06678269

Conditions
Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

NCT06246968

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer

NCT06889688

Conditions
Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Wuhan Union Hospital of China Wuhan, Hubei, China
  • Yichang Central People's Hospital Yichang, Hubei, China
View Trial Details
Recruiting

Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management

NCT07371585

Conditions
Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Gustave Roussy Villejuif, France
  • Klinikum der Universitaet Muenchen AöR München, Germany
  • Hospital Universitari Vall d'Hebrón Barcelona, Spain
  • Complexo Hospitalario Universitario A Coruna A Coruña, Spain
View all 27 locations
View Trial Details
Recruiting

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

NCT06064812

Conditions
Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Huizhou First Hospital Huizhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
View all 22 locations
View Trial Details

Related conditions